Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
•
Neuro-immunology
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
Related Questions
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
What is your approach to immune management in opsoclonus-myoclonus-ataxia syndrome?
What baseline visual testing, if any, do you recommend at diagnosis for patients with multiple sclerosis who deny visual complaints?
For patients on anti-CD20 therapy for MS without frequent/opportunistic infections, are there serum IgG levels or ALC levels in which you pause or change therapy due to low levels?
What is your approach to weaning phenobarbital and serial EEGs in patients with HIE after their perinatal seizures are under control?
What are potential pitfalls in the use of OCT to support a diagnosis of multiple sclerosis?
What are red flags in an evaluation for possible multiple sclerosis that should prompt workup for genetic/inherited conditions?
How do you decide when to pursue genetic testing for cerebral palsy?
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
Are there specific tools that you request for an IEP of a child with dyslexia?
